Evidence map›Paper›PMID 19763893›Full record

ReviewImmunologic research2010

Review: Is lung inflammation associated with microbes and microbial toxins in cigarette tobacco smoke?

John L Pauly, Lauren A Smith, Michael H Rickert, Alan Hutson, Geraldine M Paszkiewicz

Abstract readReview
PubMed Publisher
In one paragraph

Review in Immunologic research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Lung inflammation caused by inhaled toxicants: a review.International journal of chronic obstructive pulmonary disease · 2016
    Review
  6. Exacerbation of Chronic Obstructive Pulmonary Disease.Cell biochemistry and biophysics · 2015
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cigarette filter-based assays as proxies for toxicant exposure and smoking behavior--a literature review.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

John L PaulyDepartment of Immunology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. john.pauly@roswellpark.org
Lauren A Smith
Michael H Rickert
Alan Hutson
Geraldine M Paszkiewicz
Roswell Park Comprehensive Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic inflammation that has been observed for malignant and non-neoplastic lung diseases of smokers has been attributed to the numerous and diverse particulate ('tar')-phase and gas-phase chemicals in mainstream smoke, most of which arise from the burning of tobacco. The primary cell-mediator of lung inflammation is the macrophage. Most probably, inflammation is promoted also from some of the more than 50 other cell types of the lung. Cured tobacco in diverse types of cigarettes is known to harbor a plethora of bacteria (Gram-positive and Gram-negative), fungi (mold, yeast), spores, and is rich in endotoxin (lipopolysaccharide). Reviewed herein are recent observations of the authors' team and other investigators that support the hypothesis that lung inflammation of long-term smokers may be attributed in part to tobacco-associated bacterial and fungal components that have been identified in tobacco and tobacco smoke.

Indexed as

Bacterial ToxinsHumansMycotoxinsPneumoniaSmokeTobacco ProductsBacterial ToxinsMycotoxinsSmoke

Identifiers

PMID19763893
OpenAlexW2015247138

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.